Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CHAMPIONS ONCOLOGY, INC. | Director | Option to purchase Common Stock | 15.5K | $85.4K | $5.51 | Nov 3, 2023 | Direct |
Ayala Pharmaceuticals, Inc. | Director | Common Stock | 93 | $37.20 | $0.40 | Jan 19, 2023 | Direct |
Ayala Pharmaceuticals, Inc. | Director | Common Stock | 46 | $18.40 | $0.40 | Jan 19, 2023 | Held by Reporting Person's Son |
Orgenesis Inc. | Director | Stock Option | 20.5K | Dec 20, 2023 | Direct | ||
Ayala Pharmaceuticals, Inc. | Director | Stock Option | 2.34K | Jan 19, 2023 | Direct | ||
Old Ayala, Inc | Director | Common Stock | 0 | Jan 19, 2023 | Held by Reporting Person's son | ||
Old Ayala, Inc | Director | Stock Option (right to buy) | 0 | Jan 19, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ORGS | Orgenesis Inc. | Dec 20, 2023 | 1 | $0 | 4 | Dec 21, 2023 | Director |
CSBR | CHAMPIONS ONCOLOGY, INC. | Nov 3, 2023 | 1 | $85.4K | 4 | Nov 7, 2023 | Director |
AYLA | Old Ayala, Inc | Jan 19, 2023 | 3 | $0 | 4 | Jan 23, 2023 | Director |
ADXS | Ayala Pharmaceuticals, Inc. | Jan 19, 2023 | 3 | $0 | 4 | Jan 23, 2023 | Director |
ORGS | Orgenesis Inc. | Dec 23, 2022 | 1 | $0 | 4 | Dec 29, 2022 | Director |
CSBR | CHAMPIONS ONCOLOGY, INC. | Nov 1, 2022 | 1 | $80.4K | 4 | Aug 17, 2023 | Director |
CSBR | CHAMPIONS ONCOLOGY, INC. | Oct 12, 2022 | 3 | -$2 | 4 | Oct 14, 2022 | Director |
AYLA | Ayala Pharmaceuticals, Inc. | Jun 13, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
ORGS | Orgenesis Inc. | Dec 31, 2021 | 1 | $0 | 5 | Feb 14, 2022 | Director |
CSBR | CHAMPIONS ONCOLOGY, INC. | Nov 5, 2021 | 1 | $81.3K | 4 | Nov 9, 2021 | Director |
CCTS | Cactus Acquisition Corp. 1 Ltd | Oct 28, 2021 | 0 | $0 | 3 | Nov 4, 2021 | Director |
CSBR | CHAMPIONS ONCOLOGY, INC. | Oct 15, 2021 | 3 | $53K | 4 | Oct 19, 2021 | Director |
AYLA | Ayala Pharmaceuticals, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |